FogPharma was born from the scientific and entrepreneurial vision of founder Greg Verdine, a pioneer in the discovery and development of new drug classes that “drug the undruggable.”


FogPharma’s cell-penetrating miniproteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics.


Together with world-leading experts and collaborators in cancer biology and therapy, their team is building a drug discovery powerhouse having passion, knowledge, and creativity to develop fundamentally new cancer treatments.